Evaluation of the effects of multiple doses of olpasiran on baseline Lp(a), and treatment safety and tolerability
Educational Partners and Supporters
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
